139 related articles for article (PubMed ID: 23790868)
21. Triterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S in enhancing the activity of brown/beige adipocytes.
Huang Y; Wei G; Peng X; Hu G; Su H; Liu J; Chen X; Qiu M
Food Res Int; 2020 Oct; 136():109303. PubMed ID: 32846515
[TBL] [Abstract][Full Text] [Related]
22. A new nortriterpenoid and an ergostane-type steroid from the fruiting bodies of the fungus Ganoderma resinaceum.
Chen XQ; Chen LX; Li SP; Zhao J
J Asian Nat Prod Res; 2017 Dec; 19(12):1239-1244. PubMed ID: 28366021
[TBL] [Abstract][Full Text] [Related]
23. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth.
Ruan W; Lim AH; Huang LG; Popovich DG
Nat Prod Res; 2014; 28(24):2264-72. PubMed ID: 25032738
[TBL] [Abstract][Full Text] [Related]
24. Xanthine oxidase inhibitory lanostanoids from Ganoderma tsugae.
Lin KW; Chen YT; Yang SC; Wei BL; Hung CF; Lin CN
Fitoterapia; 2013 Sep; 89():231-8. PubMed ID: 23769935
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant farnesylated hydroquinones from Ganoderma capense.
Peng X; Li L; Wang X; Zhu G; Li Z; Qiu M
Fitoterapia; 2016 Jun; 111():18-23. PubMed ID: 27083379
[TBL] [Abstract][Full Text] [Related]
26. Lanostane-type triterpenoids from the fruiting bodies of Ganoderma applanatum.
Peng X; Li L; Dong J; Lu S; Lu J; Li X; Zhou L; Qiu M
Phytochemistry; 2019 Jan; 157():103-110. PubMed ID: 30390604
[TBL] [Abstract][Full Text] [Related]
27. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum.
Li C; Li Y; Sun HH
Nat Prod Res; 2006 Sep; 20(11):985-91. PubMed ID: 17050181
[TBL] [Abstract][Full Text] [Related]
28. Lanostane triterpenoids from the Sri Lankan basidiomycete Ganoderma applanatum.
de Silva ED; van der Sar SA; Santha RG; Wijesundera RL; Cole AL; Blunt JW; Munro MH
J Nat Prod; 2006 Aug; 69(8):1245-8. PubMed ID: 16933889
[TBL] [Abstract][Full Text] [Related]
29. Three new triterpenoids containing four-membered ring from the fruiting body of Ganoderma sinense.
Wang CF; Liu JQ; Yan YX; Chen JC; Lu Y; Guo YH; Qiu MH
Org Lett; 2010 Apr; 12(8):1656-9. PubMed ID: 20232901
[TBL] [Abstract][Full Text] [Related]
30. New lanostane-type triterpenoids from the fruiting body of Ganoderma hainanense.
Li W; Lou LL; Zhu JY; Zhang JS; Liang AA; Bao JM; Tang GH; Yin S
Fitoterapia; 2016 Dec; 115():24-30. PubMed ID: 27687904
[TBL] [Abstract][Full Text] [Related]
31. Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 3T3-L1 cells.
Lee I; Kim H; Youn U; Kim J; Min B; Jung H; Na M; Hattori M; Bae K
Planta Med; 2010 Oct; 76(14):1558-63. PubMed ID: 20422507
[TBL] [Abstract][Full Text] [Related]
32. Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase.
Wang K; Bao L; Xiong W; Ma K; Han J; Wang W; Yin W; Liu H
J Nat Prod; 2015 Aug; 78(8):1977-89. PubMed ID: 26287401
[TBL] [Abstract][Full Text] [Related]
33. [Anti-tumor target prediction and activity verification of Ganoderma lucidum triterpenoids].
Du GH; Wang HX; Yan Z; Liu LY; Chen RY
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(3):517-522. PubMed ID: 28952258
[TBL] [Abstract][Full Text] [Related]
34. A new lanostane triterpenoid from
Yang Q; He K; Qiu S; Zheng A; Hu Q; Ma Z; Dong M; Zhou M
J Asian Nat Prod Res; 2020 Nov; 22(11):1095-1099. PubMed ID: 31755308
[TBL] [Abstract][Full Text] [Related]
35. Anti-HIV-1 protease activity of lanostane triterpenes from the vietnamese mushroom Ganoderma colossum.
El Dine RS; El Halawany AM; Ma CM; Hattori M
J Nat Prod; 2008 Jun; 71(6):1022-6. PubMed ID: 18547117
[TBL] [Abstract][Full Text] [Related]
36. Hepatoprotective, antinociceptive and antioxidant activities of cimetidine, ranitidine and famotidine as histamine H2 receptor antagonists.
Ahmadi A; Ebrahimzadeh MA; Ahmad-Ashrafi S; Karami M; Mahdavi MR; Saravi SS
Fundam Clin Pharmacol; 2011 Feb; 25(1):72-9. PubMed ID: 20070855
[TBL] [Abstract][Full Text] [Related]
37. Tubulin polymerization-stimulating activity of Ganoderma triterpenoids.
Kohno T; Hai-Bang T; Zhu Q; Amen Y; Sakamoto S; Tanaka H; Morimoto S; Shimizu K
J Nat Med; 2017 Apr; 71(2):457-462. PubMed ID: 28078535
[TBL] [Abstract][Full Text] [Related]
38. Distinct Responses of Cytotoxic Ganoderma lucidum Triterpenoids in Human Carcinoma Cells.
Ruan W; Wei Y; Popovich DG
Phytother Res; 2015 Nov; 29(11):1744-52. PubMed ID: 26292672
[TBL] [Abstract][Full Text] [Related]
39. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity.
Seo HW; Hung TM; Na M; Jung HJ; Kim JC; Choi JS; Kim JH; Lee HK; Lee I; Bae K; Hattori M; Min BS
Arch Pharm Res; 2009 Nov; 32(11):1573-9. PubMed ID: 20091270
[TBL] [Abstract][Full Text] [Related]
40. Leucocontextins A-R, lanostane-type triterpenoids from Ganoderma leucocontextum.
Zhao ZZ; Chen HP; Li ZH; Dong ZJ; Bai X; Zhou ZY; Feng T; Liu JK
Fitoterapia; 2016 Mar; 109():91-8. PubMed ID: 26687559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
